Speaker illustration

Doctor Clotilde Roy

Jolimont Lobbes Hospital, La Louviere (Belgium)

Fibroblast growth factor 23 and extracellular volume as markers of myocardial fibrosis and poor outcome in heart failure with preserved ejection fraction

Event: ESC Congress 2018

Topic: Biomarkers

Session: Exploring biomarkers in heart failure

Thumbnail

Usefulness of fibroblast growth factor 23 and soluble suppression of tumorigenicity 2 as predictors of poor outcome in heart failure with preserved ejection fraction

Event: ESC Congress 2018

Topic: Biomarkers

Session: Exploring biomarkers in heart failure

Thumbnail

Elevated suppression of tumorigenicity 2 associated with poor outcome in heart failure with preserved ejection fraction

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Diagnostics - From epicardial fatty tissue to biomarkers and echocardiography

Thumbnail

Prognostic relevance of right ventricle global longitudinal strain in heart failure with preserved ejection fraction.

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Moderated Poster session 1 - Diagnosis and biomarkers

Thumbnail

Age and gender interaction with t1, t2, t2* and extracellular volume reference values in healthy volunteers at 3 tesla cardiac magnetic resonance.

Event: EuroCMR 2017

Topic: Cardiac Magnetic Resonance

Session: Oral abstract session 4

Thumbnail

This platform is supported by

logo Novo Nordisk